Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Review Article

Effective Agents Targeting the Mitochondria and Apoptosis to Protect the Heart

Author(s): Eltyeb Abdelwahid*, Aurimas Stulpinas and Audrone Kalvelyte

Volume 23, Issue 8, 2017

Page: [1153 - 1166] Pages: 14

DOI: 10.2174/1381612822666161229150120

Price: $65


A wide variety of agents have been traditionally used in cardiovascular medicine worldwide and their precise mechanisms of action have been demonstrated to be largely related to the cardiomyocyte mitochondria and apoptosis. Abnormalities in the structure and function of the mitochondria and mutations in mitochondrial DNA can decrease energy production, alter the redox system, impair calcium homeostasis, and induce the mitochondrial permeability transition pore (MPTP), causing cell death. All of these data provide evidence of mitochondrial signaling pathways as targets to downregulate cardiac cell apoptosis and thus to prevent and treat cardiovascular diseases. This review focuses on the protective roles of various agents, mostly natural compounds, which express beneficial effects on mitochondrial function and suspend the apoptotic signaling mechanisms by modulating the activity of mitogen-activated protein kinases (MAPKs). Examining cellular and molecular targets of these agents offers essential experimental information for future pharmacological studies, drug discovery, clinical trials and applications.

Keywords: Apoptosis, mitochondria, heart, cardioprotection, drugs.

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy